» Authors » Lihu Gu

Lihu Gu

Explore the profile of Lihu Gu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 598
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng C, Qian M, Huang T, Liu X, Zeng X, Chen X, et al.
Clin Med Insights Oncol . 2024 Sep; 18:11795549241272654. PMID: 39233761
Background: Patients with gastric cancer (GC) who underwent radical surgery require long-term follow-up (usually 5 years). The purpose of this study was to explore individualized follow-up strategies for patients with...
2.
Zhang X, Ruan J, He Y, Xu A, Fang Y, Zhang Q, et al.
Front Nutr . 2024 Aug; 11:1388557. PMID: 39119468
Background: Previous studies have suggested a correlation between dietary inflammatory potential and non-alcoholic fatty liver disease (NAFLD). Therefore, the study aimed to investigate the association between dietary inflammatory potential, measured...
3.
Dai M, Dai S, Gu L, Xiang Z, Xu A, Lu S, et al.
J Clin Res Pediatr Endocrinol . 2024 Jun; 16(3):323-333. PMID: 38828884
Objective: The aim of this meta-analysis was to investigate the effect of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on blood glucose and weight in adolescents with overweight/obesity and/or type 2 diabetes...
4.
Huang T, Zhang X, Yan K, Lou D, He Y, Dai S, et al.
Eur J Gastroenterol Hepatol . 2023 Jul; 35(9):1004-1011. PMID: 37395216
Background: This study aimed to investigate the efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of patients with pyrrolidine alkaloids-induced hepatic sinusoidal obstruction syndrome (PA-HSOS). Methods:...
5.
Gu L, Huang T, Qiu S, Hong J, Fu R, Ni C, et al.
Front Pharmacol . 2022 Nov; 13:1009254. PMID: 36386140
This study aimed to investigate the clinical efficacy of programmed death-1 receptor and ligand-1 (PD-1/PD-L1) inhibitors in gastroesophageal cancer patients and the relationship between their clinicopathological features and curative treatment...
6.
Lou D, Fu R, Gu L, Su H, Guan L
Expert Rev Clin Pharmacol . 2022 Aug; 15(9):1127-1138. PMID: 35947078
Background And Aims: Previous research has revealed the role of statins in cancer prevention and treatment. This study aimed to determine the relationship between statins' exposure and the incidence and...
7.
Zhou B, Shi Y, Fu R, Ni H, Gu L, Si Y, et al.
Front Endocrinol (Lausanne) . 2022 Jun; 13:907340. PMID: 35692406
Background: This meta-analysis was conducted to explore the association between sodium-glucose cotransporter 2 inhibitors (SGLT-2is) and ocular diseases in type 2 diabetes mellitus (T2DM) patients. Methods: PubMed, Cochrane Central Registry...
8.
Gu L, Fu R, Hong J, Ni H, Yu K, Lou H
Front Nutr . 2022 May; 9:871682. PMID: 35586738
Background: The popularity of applying intermittent fasting (IF) has increased as more and more people are trying to avoid or alleviate obesity and metabolic disease. This study aimed to systematically...
9.
Fan X, Gu L, Lv S, Zhang M, Zhuang L, Zhang Y, et al.
Bioengineered . 2022 Mar; 13(4):9046-9058. PMID: 35354382
Primary liver cancer (PLC) significantly affects the health of patients globally owing to its high morbidity and low survival rate. Radiofrequency ablation (RFA) has recently been introduced for the clinical...
10.
Gu L, Dai W, Fu R, Lu H, Shen J, Shi Y, et al.
Front Oncol . 2021 Oct; 11:753209. PMID: 34660318
Background: The purpose of this meta-analysis was to compare the safety and efficacy between hypofractionated and conventional fractionation radiotherapy in patients with early-stage breast cancer after breast-conserving surgery. Methods: We...